CDMO (API & HPAPI)/ Generics/ Security of supply/ Regulatory submission expertise/ Track record performance/ FDA inspected/ GMP certified.
MINAKEM HIGH POTENT (MHP) was established in June 2015 following the acquisition by Minafin Group of the former Ajinomoto OmniChem Louvain-la-Neuve dedicated HAPI site.
With R&D, production and regulatory affairs all integrated on a single site we offer a complete range of CDMO services from development to production of highly potent APIs down to OEB 5 (OEL 0.1μg/m3/shift).
In trusted long-term partnerships, we enable pharmaceutical and biotechnological companies to develop and provide innovative treatments of the highest quality to their patients globally.
MHP is fully GMP compliant and FDA inspected production site that can also pr...